fr 41565 has been researched along with romurtide in 2 studies
Studies (fr 41565) | Trials (fr 41565) | Recent Studies (post-2010) (fr 41565) | Studies (romurtide) | Trials (romurtide) | Recent Studies (post-2010) (romurtide) |
---|---|---|---|---|---|
57 | 0 | 8 | 101 | 10 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cartwright, N; Evans, TW; McMaster, SK; Mitchell, JA; Murch, O; Paul-Clark, MJ; Quesniaux, VF; Ryffel, B; Thiemermann, C; van Heel, DA | 1 |
Endo, Y; Sato, T; Shikama, Y; Shimauchi, H; Takada, H | 1 |
2 other study(ies) available for fr 41565 and romurtide
Article | Year |
---|---|
Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adaptor Proteins, Signal Transducing; Adjuvants, Immunologic; Animals; Antithrombin III; Aorta; Blood Pressure; Cytokines; Heart Rate; Kidney; Lipopolysaccharides; Mice; Multiple Organ Failure; Muscle Contraction; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neutrophils; Nitric Oxide Synthase Type II; Nod1 Signaling Adaptor Protein; Oligopeptides; Pancreas; Peptide Hydrolases; Shock | 2007 |
Analgesic effects of chemically synthesized NOD1 and NOD2 agonists in mice.
Topics: Acetic Acid; Acetylmuramyl-Alanyl-Isoglutamine; Analgesics; Animals; Diaminopimelic Acid; Drug Antagonism; Female; Interleukin-1; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Naloxone; Narcotic Antagonists; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Oligopeptides; Pain; Pain Measurement; Time Factors; Tumor Necrosis Factor-alpha | 2011 |